The authors of this study, published in the journal Vaccine, analyzed advantages and disadvantages of different ways vaccine manufacturers access new technologies. Among the methods considered were collaborations with academia and research institutions; technology transfer agreements with multinational corporations, public sector, or developing country organizations; and importation and finishing of bulk products.

Author(s): Milstien J, Gaule G, Kaddar M

Published: 2007

Resource types: Peer-reviewed journal

Diseases: Not disease/vaccine specific

Topics: Service delivery

Regions: Africa; Asia; Latin America